212 related articles for article (PubMed ID: 1148499)
21. The effect of ethanol on some serotonergic mechanisms in rat blood platelets.
Chabielska E; Pietraszek M; Malinowska B; Buczko W
Pol J Pharmacol Pharm; 1988; 40(3):241-9. PubMed ID: 3241765
[TBL] [Abstract][Full Text] [Related]
22. Uptake of 5-hydroxytryptamine and dopamine into platelets from depressed patients and normal subjects--influence of clomipramine, desmethylclomipramine and maprotiline.
Ehsanullah RS
Postgrad Med J; 1980; 56 Suppl 1():31-5. PubMed ID: 7393826
[TBL] [Abstract][Full Text] [Related]
23. The actions of flupenthixol upon 5-hydroxytryptamine-induced aggregation and the uptake of 5-hydroxytryptamine and dopamine by human blood platelets.
Boullin DJ; Grimes RP; Orr MW
Br J Pharmacol; 1975 Dec; 55(4):555-7. PubMed ID: 2360
[TBL] [Abstract][Full Text] [Related]
24. Effects of nomifensine in vitro on uptake of 5-hydroxytryptamine and dopamine into human platelets.
Ehsanullah RS; Turner P
Br J Clin Pharmacol; 1977; 4Suppl 2(Suppl 2):159S-163S. PubMed ID: 911650
[TBL] [Abstract][Full Text] [Related]
25. Naftidrofuryl inhibits the release of 5-hydroxytryptamine and platelet-derived growth factor from human platelets.
Barradas MA; Jagroop IA; Mikhailidis DP
Clin Chim Acta; 1994 Oct; 230(2):157-67. PubMed ID: 7834867
[TBL] [Abstract][Full Text] [Related]
26. The effect of aspirin on 5-hydroxytryptamine uptake and release by human platelets.
Rendu F
Br J Pharmacol; 1976 May; 57(1):149-51. PubMed ID: 1276534
[TBL] [Abstract][Full Text] [Related]
27. Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine.
Crespi D; Mennini T; Gobbi M
Br J Pharmacol; 1997 Aug; 121(8):1735-43. PubMed ID: 9283711
[TBL] [Abstract][Full Text] [Related]
28. The fenfluramine metabolite (+)-norfenfluramine is vasoactive.
Ni W; Li MW; Thakali K; Fink GD; Watts SW
J Pharmacol Exp Ther; 2004 May; 309(2):845-52. PubMed ID: 14752059
[TBL] [Abstract][Full Text] [Related]
29. Chronic fenfluramine administration increases plasma serotonin (5-hydroxytryptamine) to nontoxic levels.
Zolkowska D; Baumann MH; Rothman RB
J Pharmacol Exp Ther; 2008 Feb; 324(2):791-7. PubMed ID: 18032571
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of rat platelet 5-hydroxytryptamine uptake by chlordimeform.
Johnson TL; Knowles CO
Toxicol Lett; 1981 Sep; 9(1):1-4. PubMed ID: 7302966
[TBL] [Abstract][Full Text] [Related]
31. Reversible, short-lasting, and dose-dependent effect of (+)-fenfluramine on neocortical serotonergic axons.
Kalia M
Brain Res; 1991 May; 548(1-2):111-25. PubMed ID: 1868326
[TBL] [Abstract][Full Text] [Related]
32. d-Fenfluramine and d-norfenfluramine hypophagias do not require increased hypothalamic 5-hydroxytryptamine release.
Oluyomi AO; Gibson EL; Barnfield AM; Curzon G
Eur J Pharmacol; 1994 Oct; 264(1):111-5. PubMed ID: 7828639
[TBL] [Abstract][Full Text] [Related]
33. Hyperthermia induced by amphetamine, p-chloroamphetamine and fenfluramine in the rat-1.
Frey H-H
Pharmacology; 1975; 13(2):163-76. PubMed ID: 124876
[TBL] [Abstract][Full Text] [Related]
34. The uptake of 6-methoxy-1,2,3,4-tetrahydro-beta-carboline and its effect on 5-hydroxytryptamine uptake and release in blood platelets.
Airaksinen MM; Huang JT; Ho BT; Taylor D; Walker K
Acta Pharmacol Toxicol (Copenh); 1978 Nov; 43(5):375-80. PubMed ID: 726902
[TBL] [Abstract][Full Text] [Related]
35. The effect of fenfluramine on the pulmonary disposition of 5-hydroxytryptamine in the isolated perfused rat lung: a comparison with chlorphentermine.
Valodia P; Syce JA
J Pharm Pharmacol; 2000 Jan; 52(1):53-8. PubMed ID: 10716603
[TBL] [Abstract][Full Text] [Related]
36. Studies on antihistaminic action. II: In vitro and in vivo effect of chlorpheniramine and its analogs on the uptake and retention of 5-hydroxytryptamine by rabbit blood platelets.
Siva Sankar DV; Cusimano V; Santare M
J Med; 1978; 9(6):511-7. PubMed ID: 88496
[TBL] [Abstract][Full Text] [Related]
37. Backward walking and circling: behavioural responses induced by drug treatments which cause simultaneous release of catecholamines and 5-hydroxytryptamine.
Curzon G; Fernando JC; Lees AJ
Br J Pharmacol; 1979 Aug; 66(4):573-9. PubMed ID: 465894
[TBL] [Abstract][Full Text] [Related]
38. Endotoxin and dietary amines may increase plasma 5-hydroxytryptamine in the horse.
Bailey SR; Cunningham FM; Elliott J
Equine Vet J; 2000 Nov; 32(6):497-504. PubMed ID: 11093623
[TBL] [Abstract][Full Text] [Related]
39. Parthenolide inhibits the contractile responses of rat stomach fundus to fenfluramine and dextroamphetamine but not serotonin.
Béjar E
J Ethnopharmacol; 1996 Jan; 50(1):1-12. PubMed ID: 8778501
[TBL] [Abstract][Full Text] [Related]
40. Effect of amphetamine and fenfluramine on brain noradrenaline and MOPEG-SO4.
Calderini G; Morselli PL; Garattini S
Eur J Pharmacol; 1975 Dec; 34(2):345-50. PubMed ID: 1234553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
